Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

DERMA SCIENCES, INC. (DSCI)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-15Dec-31-14Dec-31-13Dec-31-12Dec-31-11Dec-31-10Dec-31-09Dec-31-08
   10-K10-K10-K10-K10-K10-K10-K10-K
Operating Activities          
Net loss  -38.1-39.8-24.0-12.1-4.3-2.4  
   
Adjustments to reconcile net loss to net cash used in operating activities:          
    Amortization of Intangible Assets  3.03.12.82.31.61.7  
    Provision for bad debts  0.00.10.00.00.00.0  
    Allowance for sales adjustments  0.20.00.00.10.00.0  
    Provision for inventory obsolescence  0.50.10.00.41.10.3  
    Deferred rent  -0.10.30.0     
    Stock-based compensation  4.85.65.32.21.60.7  
    Deferred income taxes  -2.70.00.1-2.50.10.2  
    Loss on disposal of equipment  0.00.00.00.00.00.0  
    Changes in operating assets and liabilities:          
        Accounts receivable  0.3-1.4-0.3-0.3-0.8-2.1  
        Notes receivable  0.3-1.4-0.3-0.3-0.8-2.1  
        Inventories  -9.12.6-3.0-3.3-0.3-1.1  
        Prepaid expenses and other assets  1.80.2-0.7-0.8-0.4-0.1  
        Accounts payable  -1.60.70.6-0.40.20.4  
        Accrued expenses and other liabilities  4.61.60.91.40.20.8  
        Net cash used in operating activities  -35.4-26.0-17.2-11.90.2-0.3  
   
Investing Activities          
Acquisition of a business, net of cash acquired     -14.4    
Purchase of investments  -55.0-91.5-33.7-6.5-5.5   
Proceeds from sale of investments  86.050.514.57.7    
Purchase of equipment and improvements  -1.8-1.7-0.7-0.8-1.0-0.6  
    Net cash provided by investing activities  29.2-43.9-20.3-16.2-7.5-2.9  
   
Financing Activities          
Proceeds fro m issuance of common stock, net of issuance costs   80.6 51.527.04.5  
Payment of withholding taxes related to employee stock-based compensation  -0.2-0.3-0.2-0.1    
    Net cash provided by financing activities  1.882.62.652.623.93.2  
   
Effect of exchange rate changes on cash and cash equivalents  0.80.2-0.20.00.00.1  
    Net increase (decrease) in cash and cash equivalents  -3.612.9-35.124.516.70.2  
   
Cash and cash equivalents          
Beginning of period  19.46.541.617.10.40.2  
End of period  15.819.46.541.617.10.4  
   
Supplemental disclosures of cash flow information:          
    Non-cash investing and financing activities          
    Issuance of common stock       -2.4  
    Cash paid during the period for:          
        Taxes  0.00.1  0.30.1  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy